Medtronic PLC (MDT) - Stock Price & Dividends

Exchange: USA Stocks • Country: Ireland • Currency: USD • Type: Common Stock • ISIN: IE00BTN1Y115

Medtronic plc is a global leader in developing, manufacturing, and distributing medical devices used in various therapies. They cater to healthcare systems, physicians, clinicians, and patients worldwide.

The company's Cardiovascular Portfolio segment offers a wide range of cardiac devices including pacemakers, defibrillators, and cardiac resynchronization therapy devices. They also provide products for cardiac ablation, monitoring systems, and remote patient-centered software. Additionally, their offerings include aortic valves, stent grafts, transcatheter pulmonary valves, and coronary intervention products.

In the Medical Surgical Portfolio segment, Medtronic provides surgical stapling devices, vessel sealing instruments, wound closure products, electrosurgery tools, and robotic-assisted surgery products. They offer therapies for various diseases, hernia repair devices, gynecological products, and minimally invasive gastrointestinal diagnostics.

The Neuroscience Portfolio features products for a diverse range of specialists including spinal surgeons, neurologists, and pain management experts. Medtronic also offers image-guided surgery and robotic guidance systems for spine procedures and therapies related to brain vasculature.

Within the Diabetes Operating Unit, Medtronic specializes in insulin pumps, continuous glucose monitoring systems, smart insulin pen solutions, and related supplies. The company, founded in 1949 and headquartered in Dublin, Ireland, continues to innovate and provide cutting-edge medical technologies. For more information, you can visit their website at https://www.medtronic.com.

AI improved, may contain errors or wrong assumptions

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Medtronic PLC (MDT) - Stock Price & Dividends

MDT Stock Overview

Market Cap in USD 112,249m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1978-01-13

MDT Stock Ratings

Fundamental 3.89
Dividend 7.36
Growth 5y -0.52
Rel. Performance vs Sector -1.10
Analysts 3.70
Fair Price Total Ret. 76.33
Fair Price DCF 83.38

MDT Dividends

Yield 12m 3.28%
Yield on Cost 5y 3.40%
Dividends CAGR 5y 5.34%
Payout Consistency 97.8%

MDT Growth Ratios

Growth 12m 4.68%
Growth Correlation 12m 1%
Growth Correlation 3m 54%
CAGR 5y 0.71%
CAGR / Mean Drawdown 0.04
Sharpe Ratio 12m -0.03
Alpha vs SP500 12m -22.89
Beta vs SP500 5y weekly 0.91
CAPM 7.74%
Average Daily Range 2m 1.65%
Regime Oscillator 32.43
Volatility GJR Garch 1y 18.15%
Price / SMA 50 -1.36%
Price / SMA 200 3.14%
Current Volume 4546.4k
Average Volume 20d 6579.4k

External Links for MDT Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
X (Twitter)Stocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of MDT stocks?
As of February 28, 2024, the stock is trading at USD 83.84 with a total of 4,546,366 shares traded.
Over the past week, the price has changed by -2.34%, over one month by -3.12%, over three months by +7.02% and over the past year by +3.94%.
Why is MDT stock down?
Check with which Index or Commodity MDT has the highest Correlation, do they have a common driver?
Review the Fundamentals to find weaknesses (Debt, low returns). Check the Performance of the Peer-Group to find out, if the entire sector is under pressure.
Period Return MDT Return S&P 500
1 Month -3.12% 4.00%
3 Months 7.02% 11.99%
12 Months 3.94% 29.39%
What is the forecast for MDT stock price target?
According to ValueRays Forecast Model, MDT Medtronic PLC will be worth about 83.9 in February 2025. The stock is currently trading at 83.84. This means that the stock has a potential upside of +0.07%.
Issuer Forecast Upside
Wallstreet Target Price 91.3 8.9%
Analysts Target Price 90.4 7.9%
ValueRay Target Price 83.9 0.1%

Medtronic PLC: Pioneering Medical Technologies

History of Innovation

Medtronic PLC began its journey in 1949, transforming the medical device industry. Founded by Earl Bakken and Palmer Hermundslie in Minneapolis, the company initially repaired medical equipment. The invention of the first battery-powered pacemaker in 1957 marked Medtronic's expansion into medical device manufacturing, setting the stage for decades of innovation in patient care.

Core Business: Life-Saving Devices

At the heart of Medtronic's operations is the development and manufacturing of groundbreaking medical devices. The company focuses on several key areas, including cardiology, diabetes, and minimally invasive therapies. These devices, such as pacemakers, insulin pumps, and surgical tools, are central to its mission of alleviating pain, restoring health, and extending life for millions worldwide.

Expanding Horizons: Side Businesses

Beyond its primary focus, Medtronic has diversified into related healthcare services and solutions. This includes monitoring and diagnostic services, healthcare management software, and other technologies designed to improve patient outcomes and streamline healthcare processes. These side businesses complement its core product offerings, addressing a broader range of healthcare needs.

Current Market Status

As of 2023, Medtronic PLC remains a leading force in the global medical technology market. With operations in over 150 countries, it continues to innovate, driven by a commitment to improving patient lives. Despite challenges in the global market, Medtronic's diverse product portfolio and strategic expansions position it well for future growth. The resilience and importance of the healthcare sector underscore Medtronic's ongoing development and relevance in a world increasingly reliant on medical technology solutions.